PARD 2021 Program

Anterior Segment

Saturday, 10 July 2021

9:00-9:05 Lihteh Wu (Costa Rica) & Arturo Ramirez Miranda (Mexico)
Welcome
9:05-9:10 Alejandro Navas (Mexico)
Subconjunctival sirolimus-loaded liposomes for the treatment of moderate to severe dry eye disease
9:10-9:15 Caberry Yu (Canada)
Pain control for corneal abrasions: a meta-analysis of six topical interventions
9:15-9:20 Shayan Shokoohi (Canada)
Effect of bevacizumab on the viability and metabolism of human corneal cells
9:20-9:25 Nikolaos Katsinas (Spain)
Olive pomace phenolic compounds can inhibit inflammatory and oxidative–related diseases of human ocular surface epithelium
9:25-9:30 Po Hsiang (Shawn) Yuan (Canada)
Retrospective large-cohort evaluation of trans-epithelial phototherapeutic keratectomy (PTK) for recurrent corneal erosion syndrome (RCES)
9:30-9:35 Roberto González-Salinas (Mexico)
Safety and Efficacy of Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: The EUROPA Study
9:35-9:40 Salvador Garza (Mexico)
Evaluation of meibography scores as age increases in Hispanic patients
9:40-9:45 Ahmed Amayem (Canada)
A Non-Contact Corneal Aesthesiometer (NCCA) Validation Study in Normal Eyes
9:45-9:50 Mhamed Ouzzani (Algeria)
Stability of Corneal Topographic Changes After Long-Term Orthokeratology
9:50-9:55 Rossen Hazarbassanov (Brazil)
Evaluation of keratoconus detection from elevation, topography and pachymetry raw data using machine learning
9:55-10:00 Ricardo Soares (Portugal)
Topical Insulin- Utility and results in refractory Neurotrophic Keratopathy in stages 2 and 3
10:00-10:05 Isaac Vidal Paredes (Mexico)
Evaluation of pirfenidone and pirfenidone-loaded liposomes for treating chemical corneal injury
10:05-10:10 Matthew Fung (Canada)
Development of a Novel Bioartificial Surgical Outflow Tract Model for Rapid Screening of Anti-Fibrotics Adjuvants
10:10-10:15 Simran Mangwani Mordani (Mexico)
Short-Term Effects on Corneal Endothelial Cell Density and Morphology After Deep Small Incision Lenticule Extraction (SMILE)
10:15-10:20 Alicia Goyeneche (Canada)
Deleterious genotoxic, metabolic, and oxidative stress effects of sunlight exposure on keratinocytes and fibroblasts
10:20-10:25 Judith Zavala (Mexico)
Restoration of corneal clarity after transplantation of an engineered corneal endothelium: preliminary in vivo model
10:25-10:30 Luis Rodríguez (Mexico)
Accelerated corneal cross-linking in pediatric patients with keratoconus from the northeast of Mexico: A 3-year follow-up
10:30-10:35 Renato Leca (Brazil)
Study of the corneal temperature variation during photo-refractive procedures
10:35-10:40 María Pinazo-Durán (Spain)
Characterization of dolphin tear metabolomics
10:40-10:45 Ignacio Rodríguez-Una (Spain)
Early lensectomy in patients with pseudoexfoliation: long-term outcomes of effectiveness and safety
10:45-10:50 Miguel Hernández-Delgado (Mexico)
Patient profile and outcomes regarding intraocular lens type selection in presbyopic hispanic population
10:50-10:55 Anna Paula Nassaralla (Brazil)
Impact of visual changes on falls and postural control in patients diagnosed with senil cataract in Anápolis, Goiás, Brazil
10:55-11:00 Georges Nassrallah (Canada)
Objective Analysis of Capsulorhexis factors and Posterior Capsular Opacification in 246 Post-Mortem Eyes
11:00-11:05 José A Villa-Carpes (Spain)
Visual Acuity Changes with Time Following Vision through Bangerter Filters
11:05-11:10 Andrew Smith ()
The cost, components and affordability of eye examinations in optometry practices in Western Nova Scotia, Canada.
11:10-11:15 Denise Loya (Mexico)
Scleral lenses for the management of corneal irregularities. Visual and aberrometric outcomes in Mexico.
11:15-11:20 Rémy Marcotte-Collard (Canada)
The Effect of Optic Zone Diameter on Choroidal Response Using Bifocal Soft Multifocal Contact Lenses
11:20-11:25 Adnan Alawami (Canada)
Visual Outcomes and Complications of Corneal Transplant With and Without Previous Glaucoma Surgery
11:25-11:30 Dominique Geoffrion (Canada)
Tear film cytokine profiles of Boston keratoprosthesis patients with and without glaucoma
11:30-11:35 José A. Fernández-Albarral (Spain)
Changes in cytokine and growth factor levels at different time points after experimental glaucoma induction.
11:35-11:40 Perrine Tami (Canada)
Factors Influencing Follow-up Appointment Delays in Glaucoma Practices
11:40-11:45 Mónica Melo (Brazil)
Association of ABCA1 rs2472493 and GAS7 rs9913911 variants with POAG in a Brazilian population
11:45-11:50 María del Mar Schilt-Catafal (Spain)
Quantitative analysis of the three macular capillary plexuses in Open-Angle Glaucoma and Ocular Hypertension using optical coherence tomography angiography (OCTA)
11:50-11:55 Faisal Jarrar (Canada)
Optic Disc Photography vs. Optical Coherence Tomography (OCT) in Detection of Glaucoma Progression
11:55-12:00 Emiliano Terán (Mexico)
Machine-Learning Predictor of Refractive Error from Foveal Pit Characteristics
12:00-12:05 Irving Domínguez Varela (Mexico)
Ophthalmological care during COVID-19 times. Perspectives from a Mexican eye healthcare system
12:05-12:10 Gustavo Gameiro (Brazil)
Orbicularis Oculi Muscle morphometry alterations in Hemifacial Spasm
12:10-12:15 Hiroaki Ito (Canada)
Histopathological and immunohistochemical study of metastatic orbital tumors
12:15-12:20 Arjan Dhoot (Canada)
Factors Affecting the Time to Publication in Ophthalmology Journals: A Comprehensive Bibliometric Analysis
12:20-12:23 Arturo Ramirez Miranda (Mexico)
Introduction of Keynote speaker Dr. Anthony Aldave
12:23-12:35 Anthony Aldave (USA)
Keynote: COVID and the Cornea: from Controversy to Consensus
12:35-12:40 Lihteh Wu (Costa Rica) & Arturo Ramirez Miranda (Mexico)
Q&A / End program / reminder for 17 July Posterior program

 

Posterior Segment

Saturday, 17 July 2021

9:00-9:05

Lihteh Wu (Costa Rica) & Arturo Ramirez Miranda (Mexico)
Welcome

9:05-9:08

Lihteh Wu (Costa Rica)
Introduction of Keynote speaker Dr. R.V. Paul Chan

9:08-9:15

R.V. Paul Chan (USA)
Keynote lecture: Innovations in ROP Management: The PAAO and Global Collaborations

9:15-9:20

Lihteh Wu (Costa Rica)
Q&A / Intro regular Program

9:20-9:25

Cody Lo (Canada)
Risk of Requiring Glaucoma Surgery following Intravitreal anti-VEGF Injections: A Case-Control Study

9:25-9:30

David Sousa (Portugal)
Retinal vascular reactivity in type 1 diabetes patients without retinopathy using optical coherence tomography angiography

9:30-9:35

Anastasiya Vinokurtseva (Canada)
Treatment of ocular inflammation: effects of COX-2 acetylating immuno-resolvents (CAIRs) in THP-1-derived macrophages and a rat model of endotoxin-induced uveitis

9:35-9:40

Bruno Ferreira (Brazil)
Assessment of Parafoveal Retinal Vasculature in Behçet’s Syndrome using Optical Coherence Tomography Angriography

9:40-9:45

Joana Mesquita (Portugal)
Comparison of Vascular Endothelial Growth Factors (VEGFs) A and B with diabetic retinopathy severity and diabetic macular edema. Correlation between growth factors and anatomical parameters

9:45-9:50

Christos Boutopoulos (Canada)
A smart vitrector equipped by a fiber-based OCT sensor mitigates simulated iatrogenic retinal injuries during vitrectomy in pigs

9:50-9:55

María Madeira (Portugal)
Retinal neurodegeneration in type 2 diabetic individuals with mild retinopathy is independent of retinopathy severity progression: a 5-year longitudinal study

9:55-10:00

María Esther Santos Blanco (Spain)
Retiprogram: A Clinical Decision Support System for Diabetic Retinopathy with Predictive Value

10:00-10:05

Anne Xuan-Lan Nguyen (Canada)
Correlating retinal blood vessel movements with other clinical signs in progressing retinal degenerations.

10:05-10:10

Manlong Xu (Canada)
How do RA and SLE patients differ while on long-term hydroxychloroquine therapy?

10:10-10:15

Alicia Canalejo (Spain)
Myopic choroidal neovascularization: prognostic factors with a PRN regimen of Anti-VEGF therapy

10:15-10:20

Armin Farahvash (Canada)
Understanding the Mechanism of Retinal Displacement Following Surgical Management of Rhegmatogenous Retinal Detachment: A Computer Simulation Model

10:20-10:25

Ojas Srivastava (Canada)
Anti-VEGF switch therapy from bevacizumab to aflibercept in radiation retinopathy secondary to uveal melanoma

10:25-10:30

Ivan Fernandez-Bueno (Spain)
Retinal cells death rates in in vitro neuroretinal degeneration model: preliminary data

10:30-10:35

Supriya Arora (Bahamas)
One year outcome and predictors of treatment outcome in central serous chorioretinopathy (CSCR): multimodal imaging based analysis

10:35-10:40

Simrat Sodhi (United Kingdom)
Utilisation of Machine Learning to quantify fluid volume of wet age-related macular degeneration (wARMD) patients based on swept-source optical coherence tomography (SS-OCT) imaging: The ONTARIO Study

10:40-10:45

Tomás Loureiro (Portugal)
Quantitative Optical Coherence Tomography Angiography Biomarkers in a Treat-and-Extend Dosing Regimen in Neovascular Age-Related Macular Degeneration: A 24-Months Follow-up Study

10:45-10:50

João Leite (Portugal)
Optical coherence tomography biomarkers as prognostic factors in diabetic macular edema treatment with ranibizumab – vitrectomized versus non-vitrectomized eyes

10:50-10:55

Timothy Yu (Canada)
Collaborative Diabetic Retinopathy Severity Classification of Optical Coherence Tomography Data through Federated Learning

10:55-11:00

Paula Subirada Caldarone (Argentina)
The neurotrophin receptor p75NTR as a new player in the development of choroidal neovascularization

11:00-11:05

Sarah Roy (Canada)
Membrane affinity of different segments of lecithin retinol acyltransferase

11:05-11:10

Kenzo Tomishige (Brazil)
Comparison of depressive symptoms between age-related macular degeneration and glaucoma patients who live in a developing country.

11:10-11:15

Natalia Binczyk (Canada)
Frequency of anti-VEGF intravitreal injections (IVI) after post-injection endophthalmitis in patients with neovascular age related macular degeneration (nvD)

11:15-11:20

Deborah Villafranca-Baughman (Canada)
Glia-derived S100ß promotes pericyte-mediated capillary constriction and reduced blood flow in glaucomatous and ischemic retinas

11:20-11:25

Inés López Cuenca (Spain)
Assessment of macular thickness changes by OCT in asymptomatic relatives of Alzheimer’s disease patients

11:25-11:30

Sabiha Hacibekiroglu (Canada)
Safe and immune-tolerant ‘designer’ RPE cells towards the treatment of age-related macular degeneration

11:30-11:35

Inés Marques (Portugal)
Microaneurysm Turnover in eyes with mild nonproliferative diabetic retinopathy is associated with progression and development of sight-threatening complications: a 5-year longitudinal study

11:35-11:40

Mariana da Palma (Brazil)
Phenotypic and genotypic spectrum of HGSNAT-related retinopathy

11:40-11:45

Elena Salobrar-García (Spain)
Choroidal changes as a biomarker of cerebral amyloid angiopathy in mild Alzheimer’s disease patients.

11:45-11:50

Bonnie He (Canada)
Outcomes of scleral buckle after failed pneumatic retinopexy

11:50-11:55

Daniela Santos (Portugal)
ACE2-overexpression protects RPE cells from inflammation and oxidative stress

11:55-12:00

Diogo Bitoque (Portugal)
PAEMA nonviral vectors display enhanced gene transfer ability in retinal cells

12:00-12:05

Mohamed Abdouh (Canada)
Effects of Spectrum of Wavelengths of Blue-Light on Retinal Pigment Epithelial Cells

12:05-12:10

Christina Mastromonaco (Canada)
Drusen Quantification of Eye Bank Eyes Implanted with or without Blue-Light Filtering IOLs: a Histopathological Study

12:10-12:15

Arthur Nassaralla (Brazil)
Predominantely hemorragic lesion in nD and response to Anti-VEGF treatment

12:15-12:20

Prisca Bustamante (Canada)
Potential mechanism of action of Mifepristone as antitumor treatment in Uveal melanoma

12:20-12:25

Kelly Coutant (Canada)
Impact of melanomic extracellular vesicles in the metastatic process of uveal melanoma

12:25-12:30

Anna Camos-Carreras (Spain)
Functional tests and ganglion cell complex measured with optical coherence tomography in Autosomal Dominant Optic Atrophy.

12:30-12:35

Sabrina Bergeron (Canada)
Optical biopsies of peri-ocular skin cancers: how OCT imaging can heighten accessibility to specialized healthcare by telemedicine.

12:35-12:40

Gustavo Ortiz-Morales (Mexico)
CyberKnife Robot-Assisted Radiosurgery for Ciliochoroidal Melanoma: Early Results in Mexico.